Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Snyder

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Plos One|January 1, 2019
A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitorMark D M Leiserson, Vasilis Syrgkanis, Amy Gilson, et al.
AIDS (London, England)|April 21, 2010
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cellsAlexandra Snyder, Zygimantas C Alsauskas, Jeremy S Leventhal, et al.
European Radiology|March 15, 2017
A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcomeHebert Alberto Vargas, Harini Veeraraghavan, Maura Micco, et al.
Journal of Gastrointestinal Oncology|June 2, 2015
Liver-directed conversion therapy in metastatic colon cancerAlexandra Snyder, Nancy Kemeny, Ali Shamseddine, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
Neoadjuvant Therapy in Clinical Stage II Pancreatic AdenocarcinomaAlexandra Snyder, Peter Allen, Ali Shamseddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor TypesRazvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancerClaire F Friedman, Alexandra Snyder Charen, Qin Zhou, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Plos One|January 1, 2019
A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitorMark D M Leiserson, Vasilis Syrgkanis, Amy Gilson, et al.
AIDS (London, England)|April 21, 2010
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cellsAlexandra Snyder, Zygimantas C Alsauskas, Jeremy S Leventhal, et al.
European Radiology|March 15, 2017
A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcomeHebert Alberto Vargas, Harini Veeraraghavan, Maura Micco, et al.
Journal of Gastrointestinal Oncology|June 2, 2015
Liver-directed conversion therapy in metastatic colon cancerAlexandra Snyder, Nancy Kemeny, Ali Shamseddine, et al.
Gastrointestinal Cancer Research : GCR|November 1, 2012
Neoadjuvant Therapy in Clinical Stage II Pancreatic AdenocarcinomaAlexandra Snyder, Peter Allen, Ali Shamseddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor TypesRazvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, et al.
Journal for Immunotherapy of Cancer|October 2, 2020
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancerClaire F Friedman, Alexandra Snyder Charen, Qin Zhou, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.
Pageof 8